Page last updated: 2024-10-22

amitriptyline and Leukemia, Lymphoid

amitriptyline has been researched along with Leukemia, Lymphoid in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Venkatakrishnan, K1
von Moltke, LL1
Obach, RS1
Greenblatt, DJ1
Pearson, D1

Other Studies

2 other studies available for amitriptyline and Leukemia, Lymphoid

ArticleYear
Microsomal binding of amitriptyline: effect on estimation of enzyme kinetic parameters in vitro.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:2

    Topics: Algorithms; Amitriptyline; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Biotrans

2000
Facial pain.
    British medical journal, 1970, Jan-03, Volume: 1, Issue:5687

    Topics: Amitriptyline; Facial Neuralgia; Herpesviridae Infections; Humans; Leukemia, Lymphoid; Neurofibromat

1970